益盛药业
(002566)
| 流通市值：19.31亿 | | | 总市值：27.57亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 234,366,000.78 | 63,554,309.91 | 115,847,462.79 | 101,981,306.14 |
| 交易性金融资产 | 400,571,059.79 | 507,572,971.73 | 454,041,839.42 | 454,508,208.42 |
| 应收票据及应收账款 | 174,628,251.08 | 158,945,799.69 | 161,985,537.56 | 164,096,520.61 |
| 其中：应收票据 | 1,405,570.2 | 619,612.8 | 842,679.46 | 1,089,433.4 |
| 应收账款 | 173,222,680.88 | 158,326,186.89 | 161,142,858.1 | 163,007,087.21 |
| 应收款项融资 | 32,620,147.29 | 55,947,268.14 | 49,482,512.25 | 57,532,269.05 |
| 预付款项 | 10,248,683.65 | 8,350,250.88 | 5,241,595.37 | 7,310,689.61 |
| 其他应收款合计 | 24,695,767.87 | 20,895,916.56 | 20,425,667.65 | 17,833,164.48 |
| 存货 | 1,575,238,923.19 | 1,581,017,839.16 | 1,605,333,846.06 | 1,613,133,248.59 |
| 其他流动资产 | 1,693,941.7 | 1,519,026.79 | 2,283,845.35 | 2,548,404.29 |
| 流动资产合计 | 2,454,062,775.35 | 2,397,803,382.86 | 2,414,642,306.45 | 2,418,943,811.19 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | 36,700 | - |
| 固定资产 | 397,115,072.2 | 405,862,497.42 | 412,761,356.68 | 421,885,930.21 |
| 使用权资产 | 10,585,028.57 | 11,266,419.75 | 12,834,919.92 | 13,940,203.5 |
| 无形资产 | 108,127,322.49 | 108,664,697.58 | 109,454,460.59 | 110,006,043.28 |
| 商誉 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 |
| 长期待摊费用 | 1,333,213.83 | 1,542,556.65 | 1,665,134.91 | 1,819,822.85 |
| 递延所得税资产 | 16,388,121.85 | 15,847,461.1 | 14,175,777.07 | 13,744,651.43 |
| 其他非流动资产 | 16,703,984.19 | 16,728,775.87 | 16,142,627.89 | 15,860,086.51 |
| 非流动资产合计 | 552,158,570.46 | 561,818,235.7 | 568,976,804.39 | 579,162,565.11 |
| 资产总计 | 3,006,221,345.81 | 2,959,621,618.56 | 2,983,619,110.84 | 2,998,106,376.3 |
| 流动负债: | | | | |
| 短期借款 | 333,221,858.34 | 288,228,800 | 348,231,111.1 | 348,231,869.43 |
| 应付票据及应付账款 | 13,166,642.33 | 11,691,311.81 | 10,663,685.39 | 15,160,917.96 |
| 应付账款 | 13,166,642.33 | 11,691,311.81 | 10,663,685.39 | 15,160,917.96 |
| 合同负债 | 10,590,160.89 | 14,769,280.64 | 8,521,712.95 | 8,433,601.1 |
| 应付职工薪酬 | 8,674,306.7 | 7,674,323.46 | 5,242,327.09 | 8,515,694.16 |
| 应交税费 | 11,901,868.89 | 9,183,064.94 | 11,856,622.88 | 12,806,943.05 |
| 其他应付款合计 | 24,896,514.58 | 27,959,861.59 | 25,403,127.71 | 32,875,214.51 |
| 一年内到期的非流动负债 | 2,677,740.11 | 2,697,933.42 | 4,024,203.09 | 3,601,898.24 |
| 其他流动负债 | 13,382,232.32 | 21,899,083.1 | 1,092,642.53 | 1,079,156.07 |
| 流动负债合计 | 418,511,324.16 | 384,103,658.96 | 415,035,432.74 | 430,705,294.52 |
| 非流动负债: | | | | |
| 长期借款 | 129,700,000 | 129,700,000 | 129,700,000 | 129,880,000 |
| 租赁负债 | 3,436,086.34 | 5,341,226.63 | 5,114,258.56 | 6,200,478.96 |
| 递延收益 | 106,407,886.79 | 108,867,495.85 | 106,985,855.62 | 109,064,086.81 |
| 递延所得税负债 | 2,673,479.08 | 2,339,823.36 | 2,025,537.31 | 2,091,256.67 |
| 非流动负债合计 | 242,217,452.21 | 246,248,545.84 | 243,825,651.49 | 247,235,822.44 |
| 负债合计 | 660,728,776.37 | 630,352,204.8 | 658,861,084.23 | 677,941,116.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,951,600 | 330,951,600 | 330,951,600 | 330,951,600 |
| 资本公积 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 |
| 盈余公积 | 147,619,593.3 | 147,619,593.3 | 145,392,996.97 | 145,392,996.97 |
| 未分配利润 | 934,394,536.31 | 918,250,249.1 | 915,605,877.34 | 910,241,314.88 |
| 归属于母公司股东权益合计 | 2,247,655,068 | 2,231,510,780.79 | 2,226,639,812.7 | 2,221,275,250.24 |
| 少数股东权益 | 97,837,501.44 | 97,758,632.97 | 98,118,213.91 | 98,890,009.1 |
| 股东权益合计 | 2,345,492,569.44 | 2,329,269,413.76 | 2,324,758,026.61 | 2,320,165,259.34 |
| 负债和股东权益合计 | 3,006,221,345.81 | 2,959,621,618.56 | 2,983,619,110.84 | 2,998,106,376.3 |
| 公告日期 | 2026-04-25 | 2026-04-17 | 2025-10-27 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |